ESR1 and breast carcinoma: Together these findings suggest that ERα stimulates miR590-5p, which, in-turn, represses FAM171A1 expression, and that the noticed increased expression of FAM171A1 might be associated with low levels of miR590-5p in ERα-negative TNBC breast cancer cells.